Clinical Trial Update: Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated) [Phase 2]

View source ↗

Summary

Investigator-initiated Phase 2 trial evaluating Saxenda (liraglutide) for weight management in adults with stable bipolar disorder. The study has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bipolar Disorder, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2024-03-27